30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Eastgate Biotech Corp (ESAQ)

Stock chart
Ticker: ESAQ


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Lukian Brian
CFO
1 purchase — total 41,459 USD
Buy 5 Jan 2015
Value US$1,801,056.85 | Price 477.93 | Shares 55,169
Buy 5 Jan 2015
Value US$3,221,969.09 | Price 102.05 | Shares 9,806
Buy 5 Jan 2015
Value US$49,750.00 | Price 0.04 | Shares 1,243,750
Buy 5 Jan 2015
Value US$44,850.00 | Price 0.04 | Shares 1,121,250
Buy 5 Jan 2015
Value US$28.86 | Price 0.04 | Shares 721
Buy 23 Sep 2014
Value US$35.00 | Price 0.06 | Shares 636
Buy 23 Sep 2014
Value US$35,000.02 | Price 0.06 | Shares 636,364
Buy 9 Jun 2014
Value US$47,000.00 | Price 0.25 | Shares 188,000
Buy 9 Jun 2014
Value US$68,400.00 | Price 0.25 | Shares 273,600
Buy 9 Jun 2014
Value US$120,000.00 | Price 0.25 | Shares 480,000
Buy 9 Jun 2014
Value US$106,800.00 | Price 0.25 | Shares 427,200
Buy 9 Jun 2014
Value US$106,800.00 | Price 0.25 | Shares 427,200
Buy 9 Jun 2014
Value US$47,000.00 | Price 0.25 | Shares 188,000
Buy 21 Mar 2014
Value US$216,000.00 | Price 0.25 | Shares 864,000
Buy 21 Mar 2014
Value US$144,000.00 | Price 0.25 | Shares 576,000
Buy 21 Mar 2014
Value US$180,000.00 | Price 0.25 | Shares 720,000
Buy 21 Mar 2014
Value US$120,000.00 | Price 0.25 | Shares 480,000
Buy 21 Mar 2014
Value US$120,000.00 | Price 0.25 | Shares 480,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2015-01-21 2015-01-05 B Purchase Lukian Brian

CFO

Executive Director
55,169 +16.9%
477.93
US$1,801,057
55,169 +16.9% 477.93 US$1,801,057
2015-01-21 2015-01-05 B Purchase SCHWARZ JOSEPH

CSO

Officer
9,806 -44.9%
102.05
US$3,221,969
9,806 -44.9% 102.05 US$3,221,969
2015-01-21 2015-01-05 B Purchase GLUSKIN ANNA E Non-Executive Director
68,069 -34.1%
80.82
US$3,844,615
68,069 -34.1% 80.82 US$3,844,615
2015-01-21 2015-01-05 B Purchase WEISSPAPIR MICHAEL

CMO

Officer
1,121,250 +14.7%
0.04
US$44,850
1,121,250 +14.7% 0.04 US$44,850
2015-01-21 2015-01-05 B Purchase Hasanagic Mirjana Mira Non-Executive Director
721 +0.0%
0.04
US$29
721 +0.0% 0.04 US$29
2014-11-12 2014-09-23 B Purchase WEISSPAPIR MICHAEL

CMO

Officer
636 +0.0%
0.06
US$35
636 +0.0% 0.06 US$35
2014-11-12 2014-09-23 B Purchase SCHWARZ JOSEPH

CSO

Officer
636,364 +20.8%
0.06
US$35,000
636,364 +20.8% 0.06 US$35,000
2014-07-14 2014-06-09 B Purchase WEISSPAPIR MICHAEL

CMO

Officer
188,000 +7.6%
0.25
US$47,000
188,000 +7.6% 0.25 US$47,000
2014-07-14 2014-06-09 B Purchase Hasanagic Mirjana Mira

President

Executive Director
273,600 +10.6%
0.25
US$68,400
273,600 +10.6% 0.25 US$68,400
2014-07-14 2014-06-09 B Purchase GLUSKIN ANNA E

CEO

Executive Director
480,000 +11.0%
0.25
US$120,000
480,000 +11.0% 0.25 US$120,000
2014-07-14 2014-06-09 B Purchase TGT INVESTMENT MANAGEMENT INC. Large shareholder
427,200 +4.0%
0.25
US$106,800
427,200 +4.0% 0.25 US$106,800
2014-07-14 2014-06-09 B Purchase Lukian Brian

CFO

Executive Director
427,200 +35.0%
0.25
US$106,800
427,200 +35.0% 0.25 US$106,800
2014-07-14 2014-06-09 B Purchase SCHWARZ JOSEPH

CSO

Officer
188,000 +7.6%
0.25
US$47,000
188,000 +7.6% 0.25 US$47,000
2014-03-31 2014-03-21 B Purchase GLUSKIN ANNA E

CEO

Executive Director
864,000 +24.7%
0.25
US$216,000
864,000 +24.7% 0.25 US$216,000
2014-03-31 2014-03-21 B Purchase Hasanagic Mirjana Mira

President

Executive Director
576,000 +28.8%
0.25
US$144,000
576,000 +28.8% 0.25 US$144,000
2014-03-31 2014-03-21 B Purchase Lukian Brian

CFO

Executive Director
720,000 +144.0%
0.25
US$180,000
720,000 +144.0% 0.25 US$180,000
2014-03-31 2014-03-21 B Purchase SCHWARZ JOSEPH

CSO

Officer
480,000 +24.0%
0.25
US$120,000
480,000 +24.0% 0.25 US$120,000
2014-03-31 2014-03-21 B Purchase WEISSPAPIR MICHAEL

CMO

Officer
480,000 +24.0%
0.25
US$120,000
480,000 +24.0% 0.25 US$120,000
Explore more

More insider trading research around Eastgate Biotech Corp